Nothing Ventured, Nothing Gained


Needham Funds' John Barr explains how and why he targets what he considers "hidden compounders," how he’s learned to hold on to them even when they’re less hidden, where he looks for downside protection, why he considers himself so lucky to do what he does, and what he thinks the market is missing in PDF Solutions, Nova, Aspen Aerogels and Vicor.

If you are a subscriber, log in to access the issue and bonus archive: